Forbes.com: CytRx Reports Good Results for ALS Drug
Of course, it's from Forbes, so it has to start with information about how the company's stock is doing.
The results really sound good, though. In animal trials, they saw some regeneration, so it's possible this drug could help ALS patients get better in the future. That future is, however, a way away.
No comments:
Post a Comment